IL32 and chronic obstructive pulmonary disease: IL-32 appears to play an important role in pathophysiologic states associated with dysregulated inflammatory responses, including rheumatoid arthritis, chronic obstructive pulmonary disease, psoriasis, and inflammatory bowel disease [13,18,32].